Kulturell ansprechende Betreuungsunterstützung
Kulturell ansprechende Unterstützungsprogrammierung für schwarze Betreuer von Menschen mit Demenz
Black family caregivers of older adults with Alzheimer's disease and/or related dementias (ADRD), have an increased mortality risk related to pre-existing health conditions and stress. Targeted, culturally responsive, health interventions that help Black ADRD caregivers to effectively manage their own health and use community preferenced ways of coping, can improve caregivers' overall health, perceived ability to provide care for a person with ADRD (self-efficacy), and increases the likelihood that they will experience benefits from caregiving. This clinical trial pilot will test the feasibility of a community based intervention designed to improve health outcomes for Black family caregivers of persons with ADRD.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
The proposed intervention is a peer-supportive and facilitator-led video teleconference program that will engage small groups of caregivers weekly over 6 weeks. Each week participants (n = 36, 2-5/group) will receive a different culturally relevant caregiving or personal health strategy to practice. During the support calls, a facilitator will provide an overview of the content covered and each participant will have the opportunity to discuss their past week and how they engaged the weekly strategy, or challenges that came up for them during the week. The format will be structured to ensure that core content is reviewed, and everyone can be equally engaged while flexible enough that caregivers can receive support in the areas they need. A battery of assessment measures will be taken at weeks 1 and 8.
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Michigan
-
Ann Arbor, Michigan, Vereinigte Staaten, 48109
- University of Michigan
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion criteria for participation are as follows:
Self-identified as Black/ African American At least 18 years old Able to speak, understand, and hear spoken English Related to, or has a close personal relationship to a person over the age of 55 that has an ADRD diagnosis or evidence of cognitive impairment Regular access to a smartphone, tablet or computer with internet access that will allow video conferencing engagement.
Provides monitoring, and assistance in activities of daily living and or other care tasks for the care recipient.
-
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: Caregiver Support
All participants in all groups will receive 6 weeks of caregiving support including a weekly video/teleconference call, and handouts covering relevant educational topics) |
Caregivers engage in a weekly video/teleconference support group with a skilled facilitator to discuss various strategies for managing caregiving stress, challenging behaviors, and personal self-care. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Caregiver Self-efficacy for Obtaining Respite Care
Zeitfenster: 6 weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 weeks
|
|
Caregiver Self-Efficacy for Controlling Upsetting Thoughts
Zeitfenster: 6 Weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 Weeks
|
|
Caregiver Self-Efficacy for Responding to Disruptive Behaviors
Zeitfenster: 6 Weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 Weeks
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Positive Aspects of Caregiving
Zeitfenster: 6 weeks
|
The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving. |
6 weeks
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- HUM00230940
- 1K01AG065420-01A1 (US NIH Stipendium/Vertrag)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
It is anticipated that the following data will be generated and made available 1) published tables, figures, graphs, and tables of data used for making graphs; 2) published journal papers, conference papers, annual reports and the final report; and 3) educational materials resulting from intervention development. All data will conform with relevant data and terminology standards.
IPD-Sharing-Zeitrahmen
No less than 5 years following the date of the project completion or the date of study publication.
IPD-Sharing-Zugriffskriterien
To facilitate data sharing, project data will be made publicly available via a university-managed repository Deep Blue.
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ANALYTIC_CODE
- CSR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .